Literature Collection

701

Project ECHO: Integrating Behavioral Health Care with Primary Care to Expand Access in Underserved Areas

Type: Journal Article

Authors: Miriam Komaromy, Dan Douhigg, Sanjeev Arora

Year: 2013

Topic(s):

,

Export Citation: RIS

View details

702

Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs

Type: Journal Article

Authors: H. E. Tookes, A. Oxner, D. P. Serota, E. Alonso, L. R. Metsch, D. J. Feaster, J. Ucha, E. Suarez Jr., D. W. Forrest, K. McCollister, A. Rodriguez, M. A. Kolber, T. A. Chueng, S. Zayas, B. McCoy, K. Sutherland, C. Archer, T. S. Bartholomew

Year: 2023

Topic(s):

, , ,

Reference Links:

Export Citation: RIS

View details

703

Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios

Type: Journal Article

Authors: S. Johansson, M. A. Wallander, F. J. de Abajo, L. A. Garcia Rodriguez

Year: 2010

Publication Place: New Zealand

Abstract: BACKGROUND: Post-launch drug safety monitoring is essential for the detection of adverse drug signals that may be missed during preclinical trials. Traditional methods of postmarketing surveillance such as spontaneous reporting have intrinsic limitations, many of which can be overcome by the additional application of structured pharmacoepidemiological approaches. However, further improvement in drug safety monitoring requires a shift towards more proactive pharmacoepidemiological methods that can detect adverse drug signals as they occur in the population. OBJECTIVE: To assess the feasibility of using proactive monitoring of an electronic medical record system, in combination with an independent endpoint adjudication committee, to detect adverse events among users of selected drugs. METHODS: UK General Practice Research Database (GPRD) information was used to detect acute liver disorder associated with the use of amoxicillin/clavulanic acid (hepatotoxic) or low-dose aspirin (acetylsalicylic acid [non-hepatotoxic]). Individuals newly prescribed these drugs between 1 October 2005 and 31 March 2006 were identified. Acute liver disorder cases were assessed using GPRD computer records in combination with case validation by an independent endpoint adjudication committee. Signal generation thresholds were based on the background rate of acute liver disorder in the general population. RESULTS: Over a 6-month period, 8148 patients newly prescribed amoxicillin/clavulanic acid and 5577 patients newly prescribed low-dose aspirin were identified. Within this cohort, searches identified 11 potential liver disorder cases from computerized records: six for amoxicillin/clavulanic acid and five for low-dose aspirin. The independent endpoint adjudication committee refined this to four potential acute liver disorder cases for whom paper-based information was requested for final case assessment. Final case assessments confirmed no cases of acute liver disorder. The time taken for this study was 18 months (6 months for recruitment and 12 months for data management and case validation). To reach the estimated target exposure necessary to raise or rule out a signal of concern to public health, we determined that a recruitment period 2-3 times longer than that used in this study would be required. Based on the real market uptake of six commonly used medicinal products launched between 2001 and 2006 in the UK (budesonide/eformoterol [fixed-dose combination], duloxetine, ezetimibe, metformin/rosiglitazone [fixed-dose combination], tiotropium bromide and tadalafil) the target exposure would not have been reached until the fifth year of marketing using a single database. CONCLUSION: It is feasible to set up a system that actively monitors drug safety using a healthcare database and an independent endpoint adjudication committee. However, future successful implementation will require multiple databases to be queried so that larger study populations are included. This requires further development and harmonization of international healthcare databases.

Topic(s):

Reference Links:

Export Citation: RIS

View details

704

Prospects for Care Coordination Measurement Using Electronic Data Sources

Type: Government Report

Authors: K. M. McDonald, E. Schultz, T. Chapman, S. Davies, N. Pineda, J. Lonhar, E. Schmidt, S. Wilson

Year: 2012

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

705

Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence

Type: Journal Article

Authors: Margo E. Godersky, Andrew J. Saxon, Joseph O. Merrill, Jeffrey H. Samet, Jane M. Simoni, Judith I. Tsui

Year: 2019

Topic(s):

, , ,

Export Citation: RIS

View details

706

Provider Directory Solutions: Market Assessment and Opportunities Analysis

Type: Government Report

Authors: G. Morris, S. Afzal, M. Bhasker, D. Finney

Year: 2012

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (825.31 KB)

Reference Links: PDF (825.31 KB)

Export Citation: RIS

View details

707

Provider feedback to improve 5A's tobacco cessation in primary care: a cluster randomized clinical trial

Type: Journal Article

Authors: C. J. Bentz, K. B. Bayley, K. E. Bonin, L. Fleming, J. F. Hollis, J. S. Hunt, B. LeBlanc, T. McAfee, N. Payne, J. Siemienczuk

Year: 2007

Publication Place: England

Abstract: The electronic health record (EHR) may be an effective tool to help clinicians address tobacco use more consistently. To evaluate the impact of EHR-generated practice feedback on rates of referral to a state-level tobacco quitline, we conducted a cluster randomized clinical trial (feedback versus no feedback) within 19 primary care clinics in Oregon. Intervention clinics received provider-specific monthly feedback reports generated from EHR data. The reports rated provider performance in asking, advising, assessing, and assisting with tobacco cessation compared with a clinic average and an achievable benchmark of care. During 12 months of follow-up, EHR-documented rates of advising, assessing, and assisting were significantly improved in the intervention clinics compared with the control clinics (p<.001). A higher case-mix index and presence of a clinic champion were associated with higher rates of referral to a state-level quitline. EHR-generated provider feedback improved documentation of assistance with tobacco cessation. Connecting physician offices to a state-level quitline was feasible and well accepted.

Topic(s):

Reference Links:

Export Citation: RIS

View details

708

Providing access to telehealth for addiction therapy and schyopharmacology in rural america

Type: Journal Article

Authors: Ryan Jackman, Tonya Cook, Lilia Larkin, Angela Ammon

Year: 2019

Topic(s):

, , ,

Reference Links:

Export Citation: RIS

View details

709

Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later

Type: Journal Article

Authors: A. J. Kennedy, J. S. George, G. Rossetti, C. O. Brown, K. Ragins, D. Dadiomov, R. Trotzky-Sirr, G. Sanchez, H. Llamas, B. Hurley

Year: 2023

Topic(s):

, , ,

Reference Links:

Export Citation: RIS

View details

710

Providing specialty consultant expertise to primary care: an expanding spectrum of modalities

Type: Journal Article

Authors: S. R. Kirsh, P. M. Ho, D. C. Aron

Year: 2014

Publication Place: England

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

711

Psychiatric Nurse Practitioners as Leaders in Behavioral Health Integration

Type: Journal Article

Authors: K. Birch, A. Ling, B. Phoenix

Year: 2020

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

712

Psychiatrist and Psychologist Experiences with Telehealth and Remote Collaborative Care in Primary Care: A Qualitative Study

Type: Journal Article

Authors: M. Howland, M. Tennant, D. J. Bowen, A. M. Bauer, J. C. Fortney, J. M. Pyne, J. Shore, J. M. Cerimele

Year: 2020

Publication Place: England

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

713

Psychiatrist and Psychologist Experiences with Telehealth and Remote Collaborative Care in Primary Care: A Qualitative Study

Type: Journal Article

Authors: M. Howland, M. Tennant, D. J. Bowen, A. M. Bauer, J. C. Fortney, J. M. Pyne, J. Shore, J. M. Cerimele

Year: 2021

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

714

Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials

Type: Journal Article

Authors: B. Bortolotti, M. Menchetti, F. Bellini, M. B. Montaguti, D. Berardi

Year: 2008

Publication Place: United States

Abstract: OBJECTIVE: Various studies have tested psychological therapies in the treatment of depression in primary care. Yet, concerns over their clinical effectiveness, as compared to usual general practitioner (GP) care or treatment with antidepressants, have been raised. The present meta-analysis was aimed at assessing currently available evidence on the topic. METHOD: A systematic search of electronic databases identified 10 randomized controlled trials comparing psychological forms of intervention with either usual GP care or antidepressant medication for major depression. Meta-analytical procedures were used to examine the impact of psychological intervention in primary care on depression, as compared to usual GP care and antidepressant treatment. RESULTS: The main analyses showed greater effectiveness of psychological intervention over usual GP care in both the short term [standardized mean difference (SMD)=-0.42, 95% confidence interval (CI)=-0.59 to -0.26, n=408] and long term (SMD=-0.30, 95% CI=-0.45 to -0.14, n=433). The heterogeneity test was not significant in the short term at the P<.05 level (df=5, P=.57, I(2)=0%), but it was significant in the long term (df=5, P=.004, I(2)=70.9%). The comparison between psychological forms of intervention and antidepressant medication yielded no effectiveness differences, for either the short term or the long term. CONCLUSIONS: Psychological forms of intervention are significantly linked to clinical improvement in depressive symptomatology and may be useful for supplementing usual GP care.

Topic(s):

Reference Links:

Export Citation: RIS

View details

715

Psychometric Properties of Patient-Facing eHealth Evaluation Measures: Systematic Review and Analysis

Type: Journal Article

Authors: B. J. Wakefield, C. L. Turvey, K. M. Nazi, J. E. Holman, T. P. Hogan, S. L. Shimada, D. R. Kennedy

Year: 2017

Publication Place: Canada

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

716

Put prevention into practice (PPIP): evaluating PPIP in two family practice residency sites

Type: Journal Article

Authors: M. W. Yeazel, S. H. Bunner, P. M. Kofron, P. J. Weiss

Year: 2002

Publication Place: United States

Abstract: BACKGROUND AND OBJECTIVES: The Put Prevention Into Practice (PPIP) office system is a set of office tools designed to address physician, patient, and system barriers to the provision of clinical preventive services. This study evaluated the effect of using PPIP on the delivery of clinical preventive services at two family practice residency sites. METHODS: After a careful planning process at each clinic, a 1-year trial was conducted with implementation of PPIP at two residency sites compared to two control residency sites. The subjects included adults age 19 and older Data were collected via chart extraction on 300 randomly selected patients per clinic for the following three outcomes: health risk factor assessment (for limited physical activity, poor nutrition habits, and tobacco use), health promotion/counseling (for nutrition, physical activity, and tobacco use), and screening rates (clinical breast exam, cholesterol, fecal occult blood test, mammography, and Pap smear). RESULTS: Only inconsistent or sporadic differences in risk factor assessment, health promotion counseling, and screening were seen when comparing implementation and control sites. CONCLUSIONS: PPIP had little effect on the delivery of clinical preventive services. Future research should include a careful analysis of the users of PPIP and the environments in which they practice.

Topic(s):

Reference Links:

Export Citation: RIS

View details

717

Qualitative exploration of the psychological dimensions of telehealth shared medical appointments (SMAs) for buprenorphine prescribing

Type: Journal Article

Authors: B. Greenberg, A. C. Oft, L. Lucitt, N. A. Haug, A. Lembke

Year: 2024

Abstract:

Background: Shared medical appointments (SMAs) for buprenorphine prescribing are clinical encounters in which multiple patients with opioid problems receive treatment from providers in a group setting. Telehealth, the provision of clinical services remotely using telecommunications technology, is an essential modality for improving access to healthcare when combined with SMAs, especially since the COVID pandemic. Objectives: The current study specifically examined psychological components of telehealth SMAs for buprenorphine prescribing to learn about the benefits and drawbacks of this treatment model. Methods: Data was collected through qualitative interviews with patients (N=10) in a psychiatry addiction medicine clinic. Narrative synthesis using grounded theory was conducted to identify salient themes from the interviews. Results: Findings highlighted the advantages and downsides of telehealth SMA to treat addictive disorders in a digital age: (1) Shared group identity; (2) Decreased stigma around buprenorphine; (3) Benefits of telehealth; (4) Discomfort with group SMA format; (5) Strategies for managing medication side effects; and (6) Enhanced empathy for providers. Several themes corresponded to therapeutic factors identified in group therapy (i.e., installation of hope, universality, imparting information, altruism) and mechanisms theorized in previous SMA research (e.g., combating isolation, disease self-management, feeling inspired by others). Conclusion: Telehealth SMAs for buprenorphine prescribing may be a unique opportunity for patients to receive both ongoing medication management and psychosocial benefits that promote recovery and reduce stigma. The SMA group had shortcomings for some patients, including privacy concerns, fear of judgment from other patients and limited time to discuss individual concerns with providers.

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

718

Quality of Care Perceived by Older Patients and Caregivers in Integrated Care Pathways With Interviewing Assistance From a Social Robot: Noninferiority Randomized Controlled Trial

Type: Journal Article

Authors: R. Boumans, F. van Meulen, W. van Aalst, J. Albers, M. Janssen, M. Peters-Kop, Huisman- de Waal, A. van de Poll, K. Hindriks, M. Neerincx, Olde Rikkert

Year: 2020

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

719

Quality of mental health care for children: a familiar storyline

Type: Journal Article

Authors: K. J. Kelleher, S. M. Horwitz

Year: 2006

Publication Place: United States

Topic(s):

Reference Links:

Export Citation: RIS

View details

720

Quality of mental health care for youth with asthma and comorbid anxiety and depression

Type: Journal Article

Authors: W. J. Katon, L. Richardson, J. Russo, P. Lozano, E. McCauley

Year: 2006

Publication Place: United States

Abstract: OBJECTIVES: Youth with asthma have a high rate of anxiety and depressive disorders, and these comorbid disorders are associated with increased asthma symptom burden and functional impairment. This study examined the rates and predictors of recognition of anxiety and depressive disorders among youth (ages 11 to 17) with asthma who are seen in primary care settings as well as the quality of mental health care provided to those with comorbid anxiety and depression over a 12-month period. METHODS: This study used automated utilization and pharmacy data from a health maintenance organization to describe the rate of recognition of Diagnostic and Statistical Manual of Mental Disorders, edition IV, anxiety and depressive disorders and the quality of mental health care provided for the 17% of youth with asthma and comorbid anxiety and/or depression during the 12-month period prior to diagnosis. Psychiatric diagnoses were based on a telephone version of the Computerized Diagnostic Interview Schedule for Children (Version 4.0). RESULTS: Approximately 35% of youth with 1 or more anxiety and depressive disorders and 43% of those with major depression were recognized by the medical system during a 12-month period. Greater functional impairment (odds ratio [OR] 3.32, 95% confidence interval [CI] 1.25-8.79), higher severity on parent-rated anxiety and depressive symptoms (OR 2.49, 95% CI 1.04-6.00), and a greater number of primary care visits (OR 1.26, 95% CI 1.10-1.44) were associated with significantly higher recognition rates while having Medicaid or Washington state medical insurance was associated with lower rates of recognition (OR 0.27, 95% CI 0.08-0.92). Only approximately 1 in 5 youths with comorbid major depression received an adequate dosage and duration of antidepressant medication, and only 1 in 6 received a minimally adequate number of psychotherapy sessions (> or =4 visits). CONCLUSION: Rates of recognition of comorbid anxiety and depressive disorders are low in youth with asthma and few youth with asthma and comorbid anxiety and depression receive guideline-level mental health treatment.

Topic(s):

Reference Links:

Export Citation: RIS

View details